Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

Health and Human Services Secretary Robert F. Kennedy Jr. attends a swearing in ceremony for Dr. Mehmet Oz to be ...

A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

One-third of Missouri's seniors are obese, putting them at risk of significant health issues that can be much more expensive ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 million Americans on ...

Medicare coverage for anti-obesity drugs was not finalized, affecting drugs like Wegovy and Zepbound. Covering weight loss drugs may cost $35 billion from 2026–2034, with estimated savings under ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some evidence that if Medicaid patients lose weight with the drugs, they’ll be ...

Medicare and Medicaid recipients can be reimbursed for the medications to treat diabetes, but currently the anti-obesity versions of these drugs will not be covered. As an obesity treatment, Wegovy, ...

President Donald Trump wants to move a crucial program for children with disabilities into the Department of Health and Human Services. Special education advocates and Democrats warn that his plan is ...